Analyst Reco. Artivion, Inc.

Equities

AORT

US2289031005

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
20.57 ^USD	+1.48%		+2.70%	+15.04%

Mar. 01	Artivion Files Mixed Shelf	MT
Feb. 22	Artivion Insider Sold Shares Worth $1,358,818, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stifel Raises Price Target on Artivion to $22 From $20, Maintains Buy Rating	Feb. 16	MT
Morgan Stanley Adjusts Price Target on Artivion to $15 From $14, Maintains Equal-Weight Rating	23-05-08	MT
Needham Adjusts Price Target on Artivion to $26 From $23, Maintains Buy Rating	23-05-05	MT
Needham Adjusts Price Target on Artivion to $23 From $28, Maintains Buy Rating	22-11-04	MT
Morgan Stanley Trims Artivion's Price Target to $14 From $16, Reiterates Equalweight Rating	22-10-11	MT
Oppenheimer Adjusts Artivion's Price Target to $25 From $35, Maintains Outperform Rating	22-09-27	MT
Morgan Stanley Adjusts Artivion's Price Target to $16 from $23, Maintains Equalweight Rating	22-09-26	MT
Oppenheimer Adjusts Artivion Price Target to $25 From $35, Maintains Outperform Rating	22-09-26	MT
Needham Trims Artivion's Price Target to $28 From $29, Reiterates Buy Rating	22-08-05	MT
Morgan Stanley Adjusts Artivion's Price Target to $21 from $23, Keeps Equalweight Rating	22-07-15	MT
Needham Trims Artivion's Price Target to $29 From $30, Reiterates Buy Rating	22-05-06	MT
Stifel Starts Artivion at Buy With $30 Price Target	22-03-03	MT
Needham Adjusts Artivion's Price Target to $30 From $39 on 'Peer Multiple Compression;' Buy Rating Kept	22-02-18	MT
Morgan Stanley Lowers Price Target for CryoLife to $25 From $29, Maintains Equalweight Rating	22-01-07	MT
CRYOLIFE : Needham Adjusts CryoLife's Price Target to $39 From $38, Maintains Buy Rating	21-07-30	MT
CRYOLIFE : Morgan Stanley Starts CryoLife at Equal-Weight With $31 Price Target	21-07-15	MT
CRYOLIFE : Oppenheimer Adjusts CryoLife PT to $35 From $29, Maintains Outperform Rating	21-04-30	MT
CRYOLIFE : Needham Adjusts CryoLife's Price Target to $38 From $33, Maintains Buy Rating	21-04-30	MT
CRYOLIFE : Oppenheimer Adjusts CryoLife PT to $29 From $25, Maintains Outperform Rating	21-02-12	MT
CRYOLIFE : Needham Adjusts CryoLife's Price Target to $28 from $29, Maintains Buy Rating	20-11-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Artivion, Inc.

Equities

AORT

US2289031005

Analyst Reco.

Filters